NCT02249936View on ClinicalTrials.gov

A Phase 1 Study to Examine the Pharmacodynamics of Different AZD1722 Formulations

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions

Healthy

Interventions

DRUG

AZD1722

DRUG

Omeprazole

Trial Locations (1)

68154

ICON Development Solutions, Omaha

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Ardelyx

INDUSTRY